Literature DB >> 31911437

Granulins modulate liquid-liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43.

Anukool A Bhopatkar1, Vladimir N Uversky2, Vijayaraghavan Rangachari3.   

Abstract

TAR DNA-binding protein 43 (TDP-43) has emerged as a key player in many neurodegenerative pathologies, including frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Hallmarks of both FTLD and ALS are the toxic cytoplasmic inclusions of the prion-like C-terminal fragments of TDP-43 CTD (TDP-43 C-terminal domain), formed upon proteolytic cleavage of full-length TDP-43 in the nucleus and subsequent transport to the cytoplasm. Both full-length TDP-43 and its CTD are also known to form stress granules by coacervating with RNA in the cytoplasm during stress and may be involved in these pathologies. Furthermore, mutations in the PGRN gene, leading to haploinsufficiency and diminished function of progranulin (PGRN) protein, are strongly linked to FTLD and ALS. Recent reports have indicated that proteolytic processing of PGRN to smaller protein modules called granulins (GRNs) contributes to FTLD and ALS progression, with specific GRNs exacerbating TDP-43-induced cytotoxicity. Here we investigated the interactions between the proteolytic products of both TDP-43 and PGRN. Based on structural disorder and charge distributions, we hypothesized that GRN-3 and GRN-5 could interact with the TDP-43 CTD. We show that, under both reducing and oxidizing conditions, GRN-3 and GRN-5 interact with and differentially modulate TDP-43 CTD aggregation and/or liquid-liquid phase separation in vitro GRN-3 promoted insoluble aggregates of the TDP-43 CTD while GRN-5 mediated liquid-liquid phase separation. These results constitute the first observation of an interaction between GRNs and TDP-43, suggesting a mechanism by which attenuated PGRN function could lead to familial FTLD or ALS.
© 2020 Bhopatkar et al.

Entities:  

Keywords:  ALS; ALS (Lou Gehrig disease); FTLD; Granulins; TAR DNA-binding protein 43 (TDP-43, TARDBP); intrinsically disordered protein; liquid–liquid phase separation; progranulin; protein dynamic; protein–protein interaction; stress granule

Mesh:

Substances:

Year:  2020        PMID: 31911437      PMCID: PMC7039568          DOI: 10.1074/jbc.RA119.011501

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  107 in total

1.  Protein Phase Separation Provides Long-Term Memory of Transient Spatial Stimuli.

Authors:  Elliot Dine; Agnieszka A Gil; Giselle Uribe; Clifford P Brangwynne; Jared E Toettcher
Journal:  Cell Syst       Date:  2018-05-30       Impact factor: 10.304

2.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

3.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

4.  Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury.

Authors:  Katie Moisse; Kathryn Volkening; Cheryl Leystra-Lantz; Ian Welch; Tracy Hill; Michael J Strong
Journal:  Brain Res       Date:  2008-11-01       Impact factor: 3.252

5.  Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.

Authors:  Yong-Jie Zhang; Ya-Fei Xu; Casey Cook; Tania F Gendron; Paul Roettges; Christopher D Link; Wen-Lang Lin; Jimei Tong; Monica Castanedes-Casey; Peter Ash; Jennifer Gass; Vijayaraghavan Rangachari; Emanuele Buratti; Francisco Baralle; Todd E Golde; Dennis W Dickson; Leonard Petrucelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

6.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

7.  ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain.

Authors:  Alexander E Conicella; Gül H Zerze; Jeetain Mittal; Nicolas L Fawzi
Journal:  Structure       Date:  2016-08-18       Impact factor: 5.006

8.  Sequence Determinants of Intracellular Phase Separation by Complex Coacervation of a Disordered Protein.

Authors:  Chi W Pak; Martyna Kosno; Alex S Holehouse; Shae B Padrick; Anuradha Mittal; Rustam Ali; Ali A Yunus; David R Liu; Rohit V Pappu; Michael K Rosen
Journal:  Mol Cell       Date:  2016-07-07       Impact factor: 17.970

9.  Length-dependent prediction of protein intrinsic disorder.

Authors:  Kang Peng; Predrag Radivojac; Slobodan Vucetic; A Keith Dunker; Zoran Obradovic
Journal:  BMC Bioinformatics       Date:  2006-04-17       Impact factor: 3.169

Review 10.  Phase separation in biology; functional organization of a higher order.

Authors:  Diana M Mitrea; Richard W Kriwacki
Journal:  Cell Commun Signal       Date:  2016-01-05       Impact factor: 5.712

View more
  8 in total

1.  Charge and redox states modulate granulin-TDP-43 coacervation toward phase separation or aggregation.

Authors:  Anukool A Bhopatkar; Shailendra Dhakal; Hannah G Abernathy; Sarah E Morgan; Vijayaraghavan Rangachari
Journal:  Biophys J       Date:  2022-04-30       Impact factor: 3.699

2.  Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils.

Authors:  Shailendra Dhakal; Courtney E Wyant; Hannah E George; Sarah E Morgan; Vijayaraghavan Rangachari
Journal:  J Mol Biol       Date:  2021-03-24       Impact factor: 5.469

3.  Tryptophan Probes of TDP-43 C-Terminal Domain Amyloid Formation.

Authors:  Sydney O Shuster; Jennifer C Lee
Journal:  J Phys Chem B       Date:  2021-04-09       Impact factor: 2.991

4.  Are granulins copper sequestering proteins?

Authors:  Anukool A Bhopatkar; Vijayaraghavan Rangachari
Journal:  Proteins       Date:  2020-12-09

Review 5.  Liquid-liquid phase separation of tau: From molecular biophysics to physiology and disease.

Authors:  Sandeep K Rai; Adriana Savastano; Priyanka Singh; Samrat Mukhopadhyay; Markus Zweckstetter
Journal:  Protein Sci       Date:  2021-05-14       Impact factor: 6.725

6.  FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade.

Authors:  Pierre De Rossi; Amanda J Lewis; Johanna Furrer; Laura De Vos; Tomas Demeter; Aurélie Zbinden; Weijia Zhong; Vera I Wiersma; Carlo Scialo; Julien Weber; Zhongning Guo; Stefano Scaramuzza; Marta Di Fabrizio; Carolin Böing; Daniel Castaño-Díez; Ashraf Al-Amoudi; Manuela Pérez-Berlanga; Tammaryn Lashley; Henning Stahlberg; Magdalini Polymenidou
Journal:  EMBO Rep       Date:  2021-11-22       Impact factor: 8.807

7.  Molecular mechanism for the synchronized electrostatic coacervation and co-aggregation of alpha-synuclein and tau.

Authors:  Pablo Gracia; David Polanco; Jorge Tarancón-Díez; Ilenia Serra; Maruan Bracci; Javier Oroz; Douglas V Laurents; Inés García; Nunilo Cremades
Journal:  Nat Commun       Date:  2022-08-06       Impact factor: 17.694

Review 8.  Secreted Chaperones in Neurodegeneration.

Authors:  Kriti Chaplot; Timothy S Jarvela; Iris Lindberg
Journal:  Front Aging Neurosci       Date:  2020-08-27       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.